• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子CX3CL1(fractalkine)及其受体CX3CR1:在骨关节炎中的存在情况及潜在作用

The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.

作者信息

Wojdasiewicz Piotr, Poniatowski Lukasz A, Kotela Andrzej, Deszczyński Jarosław, Kotela Ireneusz, Szukiewicz Dariusz

机构信息

Department of General and Experimental Pathology, Second Faculty of Medicine, Medical University of Warsaw, Pawinskiego 3c, 02-106, Warsaw, Poland,

出版信息

Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):395-403. doi: 10.1007/s00005-014-0275-0. Epub 2014 Feb 21.

DOI:10.1007/s00005-014-0275-0
PMID:24556958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4164853/
Abstract

Chemokines are molecules able to induce chemotaxis of monocytes, neutrophils, eosinophils, lymphocytes and fibroblasts. The complex chemokine acts in many physiological and pathological phenomena, including those occurring in the articular cartilage. To date, chemokine CX3CL1 (fractalkine) is the only member of the CX3C class of chemokines with well-documented roles in endothelial cells. CX3CL1 is a unique chemokine that combines properties of chemoattractant and adhesion molecule. The main roles of CX3CL1 include promotion of leukocyte binding and adhesion as well as activation of the target cells. The soluble chemokine domain of CX3CL1 is chemotactic for T cells and monocytes. CX3CL1 acts via its receptor, CX3CR1, which belongs to a family of G protein-coupled receptors. Stimulation of CX3CR1 activates both CX3CL1-dependent and integrin-dependent migrations of cells with synergistically augmented adhesion. Genetic polymorphisms of CX3CR1 may significantly modify the biological roles of CX3CL1, especially in pathologic conditions. Osteoarthritis (OA) is the most common joint disease, affecting approximately 7-8 % of the general population. Development of OA is largely driven by low-grade local background inflammation involving chemokines. The importance of CX3CL1/CX3CR1 signalling in the pathophysiology of OA is still under investigation. This paper, based on a review of the literature, updates and summarises the current knowledge about CX3CL1/CX3CR1 in OA and indicates possible interactions with a potential for therapeutic targeting.

摘要

趋化因子是一类能够诱导单核细胞、中性粒细胞、嗜酸性粒细胞、淋巴细胞和成纤维细胞发生趋化作用的分子。复杂的趋化因子参与多种生理和病理过程,包括发生在关节软骨中的过程。迄今为止,趋化因子CX3CL1(fractalkine)是CX3C类趋化因子中唯一在内皮细胞中具有充分记录作用的成员。CX3CL1是一种独特的趋化因子,兼具趋化剂和黏附分子的特性。CX3CL1的主要作用包括促进白细胞结合与黏附以及激活靶细胞。CX3CL1的可溶性趋化因子结构域对T细胞和单核细胞具有趋化作用。CX3CL1通过其受体CX3CR1发挥作用,CX3CR1属于G蛋白偶联受体家族。刺激CX3CR1可激活细胞依赖CX3CL1和整合素的迁移,并协同增强黏附。CX3CR1的基因多态性可能会显著改变CX3CL1的生物学作用,尤其是在病理状态下。骨关节炎(OA)是最常见的关节疾病,影响着约7% - 8%的普通人群。OA的发生很大程度上由涉及趋化因子的低度局部背景炎症驱动。CX3CL1/CX3CR1信号在OA病理生理学中的重要性仍在研究中。本文基于文献综述,更新并总结了目前关于OA中CX3CL1/CX3CR1的知识,并指出了可能的相互作用以及潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/96b4a572b427/5_2014_275_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/ab7d84d6e006/5_2014_275_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/a31bea6eaf64/5_2014_275_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/96b4a572b427/5_2014_275_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/ab7d84d6e006/5_2014_275_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/a31bea6eaf64/5_2014_275_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d31e/4164853/96b4a572b427/5_2014_275_Fig3_HTML.jpg

相似文献

1
The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.趋化因子CX3CL1(fractalkine)及其受体CX3CR1:在骨关节炎中的存在情况及潜在作用
Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):395-403. doi: 10.1007/s00005-014-0275-0. Epub 2014 Feb 21.
2
The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.CC趋化因子MCP-1通过p38丝裂原活化蛋白激酶刺激CX3CR1的表面表达,并增强单核细胞与fractalkine/CX3CL1的黏附。
J Immunol. 2006 Jun 15;176(12):7412-20. doi: 10.4049/jimmunol.176.12.7412.
3
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.CX3CL1(趋化因子)及其受体CX3CR1在创伤性脑损伤和脊髓损伤中的作用分析:深入了解神经趋化因子药物作用的最新进展
Mol Neurobiol. 2017 Apr;54(3):2167-2188. doi: 10.1007/s12035-016-9787-4. Epub 2016 Mar 1.
4
CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.CX3CL1 通过 CX3CR1、c-Raf、MEK、ERK 和 NF-κB 信号通路促进骨关节炎滑膜成纤维细胞中 MMP-3 的产生。
Arthritis Res Ther. 2017 Dec 21;19(1):282. doi: 10.1186/s13075-017-1487-6.
5
CX₃CL1 (fractalkine) and its receptor CX₃CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin.CX₃CL1(趋化因子)及其受体 CX₃CR1 通过控制效应 T 细胞在炎症皮肤中的滞留来调节特应性皮炎。
J Exp Med. 2014 Jun 2;211(6):1185-96. doi: 10.1084/jem.20121350. Epub 2014 May 12.
6
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.趋化因子(CX3CL1)及其受体CX3CR1在韦格纳肉芽肿中的表达增加——在血管炎症中的可能作用
Rheumatology (Oxford). 2007 Sep;46(9):1422-7. doi: 10.1093/rheumatology/kem168. Epub 2007 Jul 6.
7
Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes. fractalkine 诱导 CX3CR1 表达的单核细胞的血管生成潜能。
J Leukoc Biol. 2018 Jan;103(1):53-66. doi: 10.1189/jlb.1A0117-002RR. Epub 2017 Dec 28.
8
CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.在唾液腺浸润的三级淋巴结构中 CX3CL1 和 CX3CR1 的表达:趋化因子 fractalkine 对干燥综合征中淋巴新生的贡献。
Rheumatology (Oxford). 2014 Apr;53(4):611-20. doi: 10.1093/rheumatology/ket401. Epub 2013 Dec 9.
9
Fractalkine promotes human monocyte survival via a reduction in oxidative stress.趋化因子通过降低氧化应激促进人单核细胞存活。
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2554-62. doi: 10.1161/ATVBAHA.114.304717. Epub 2014 Oct 30.
10
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.趋化因子与常见变异免疫缺陷;fractalkine系统(CX3CL1/CX3CR1)对慢性炎症的可能作用。
Clin Immunol. 2009 Feb;130(2):151-61. doi: 10.1016/j.clim.2008.09.002. Epub 2008 Oct 19.

引用本文的文献

1
Innate Immunity and Synovitis: Key Players in Osteoarthritis Progression.先天免疫与滑膜炎:骨关节炎进展的关键因素。
Int J Mol Sci. 2024 Nov 11;25(22):12082. doi: 10.3390/ijms252212082.
2
CX3CR1CD8 T cells: Key players in antitumor immunity.CX3CR1阳性CD8 T细胞:抗肿瘤免疫的关键参与者。
Cancer Sci. 2024 Dec;115(12):3838-3845. doi: 10.1111/cas.16359. Epub 2024 Oct 8.
3
CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.CX3CL1(趋化因子 Fractalkine)-CX3CR1 轴在炎症诱导的血管生成和肿瘤发生中的作用。

本文引用的文献

1
Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis.血清和滑液中 fractalkine 浓度与膝关节骨关节炎放射学严重程度的相关性。
Ann Clin Biochem. 2013 Nov;50(Pt 6):571-5. doi: 10.1177/0004563213480494. Epub 2013 Jul 18.
2
Macrophages and chemokines as mediators of angiogenesis.巨噬细胞和趋化因子作为血管生成的介质。
Front Physiol. 2013 Jul 5;4:159. doi: 10.3389/fphys.2013.00159. eCollection 2013.
3
Osteoarthritis year 2013 in review: clinical.骨关节炎 2013 年年鉴:临床篇。
Int J Mol Sci. 2024 Apr 25;25(9):4679. doi: 10.3390/ijms25094679.
4
Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis.血清中趋化因子在显微镜下多血管炎和肉芽肿性多血管炎患者中的表达。
Sci Rep. 2024 Apr 15;14(1):8680. doi: 10.1038/s41598-024-59484-8.
5
Unveiling cytokine charge disparity as a potential mechanism for immune regulation.揭示细胞因子电荷量差异作为免疫调节的潜在机制。
Cytokine Growth Factor Rev. 2024 Jun;77:1-14. doi: 10.1016/j.cytogfr.2023.12.002. Epub 2023 Dec 26.
6
Recruitment and Maintenance of CX3CR1+CD4+ T Cells during Helminth Infection.在寄生虫感染期间招募和维持 CX3CR1+CD4+T 细胞。
J Immunol. 2024 Feb 15;212(4):632-644. doi: 10.4049/jimmunol.2300451.
7
Chemo Markers as Biomarkers in Septic Shock: A Comprehensive Review of Their Utility and Clinical Applications.化疗标志物作为脓毒症休克的生物标志物:对其效用和临床应用的全面综述
Cureus. 2023 Jul 27;15(7):e42558. doi: 10.7759/cureus.42558. eCollection 2023 Jul.
8
Post-traumatic osteoarthritis: A review of pathogenic mechanisms and novel targets for mitigation.创伤后骨关节炎:发病机制及缓解新靶点综述
Bone Rep. 2023 Jan 30;18:101658. doi: 10.1016/j.bonr.2023.101658. eCollection 2023 Jun.
9
CX3CL1/CX3CR1 axis alleviates inflammation and apoptosis in human nucleus pulpous cells via M2 macrophage polarization.CX3CL1/CX3CR1轴通过M2巨噬细胞极化减轻人髓核细胞中的炎症和凋亡。
Exp Ther Med. 2023 Jun 7;26(1):359. doi: 10.3892/etm.2023.12058. eCollection 2023 Jul.
10
Healthy and Osteoarthritis-Affected Joints Facing the Cellular Crosstalk.健康关节和骨关节炎关节面临的细胞串扰。
Int J Mol Sci. 2023 Feb 18;24(4):4120. doi: 10.3390/ijms24044120.
Osteoarthritis Cartilage. 2013 Oct;21(10):1409-13. doi: 10.1016/j.joca.2013.06.021. Epub 2013 Jul 4.
4
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations.炎症在骨关节炎发病机制中的作用:最新发现与诠释。
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94. doi: 10.1177/1759720X12467868.
5
An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid.一项探索性研究比较了对照和骨关节炎滑液中可溶性介质的水平。
Osteoarthritis Cartilage. 2013 Jul;21(7):918-22. doi: 10.1016/j.joca.2013.04.002. Epub 2013 Apr 15.
6
Biologic agents in osteoarthritis: hopes and disappointments.骨关节炎的生物制剂:希望与失望。
Nat Rev Rheumatol. 2013 Jul;9(7):400-10. doi: 10.1038/nrrheum.2013.44. Epub 2013 Apr 2.
7
Immunopathogenesis of osteoarthritis.骨关节炎的免疫发病机制。
Clin Immunol. 2013 Mar;146(3):185-96. doi: 10.1016/j.clim.2012.12.011. Epub 2013 Jan 6.
8
Antimicrobial activities of chemokines: not just a side-effect?趋化因子的抗菌活性:不仅仅是一种副作用?
Front Immunol. 2012 Jul 23;3:213. doi: 10.3389/fimmu.2012.00213. eCollection 2012.
9
Chemokine receptor oligomerization: a further step toward chemokine function.趋化因子受体寡聚化:向趋化因子功能迈进的又一步。
Immunol Lett. 2012 Jul 30;145(1-2):23-9. doi: 10.1016/j.imlet.2012.04.012.
10
Overview of the mechanisms regulating chemokine activity and availability.概述调节趋化因子活性和可及性的机制。
Immunol Lett. 2012 Jul 30;145(1-2):2-9. doi: 10.1016/j.imlet.2012.04.015.